...
search icon
anvs-img

Annovis Bio Inc, Common Stock

ANVS

NYQ

$1.55

-$0.02

(-1.27%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$26.31M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
125.28K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.51
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.11 L
$17.88 H
$1.55

About Annovis Bio Inc, Common Stock

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameANVSSectorS&P500
1-Week Return14.81%4.13%7.14%
1-Month Return-6.06%-4.48%-0.92%
3-Month Return-68.11%-5.78%-8.95%
6-Month Return-84.02%-7.23%-5.21%
1-Year Return-78.71%-1.69%7.95%
3-Year Return-84.65%3.23%28.74%
5-Year Return-59.21%38.7%92.67%
10-Year Return-83.84%88.08%161.14%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses5.48M14.50M25.51M45.04M26.69B[{"date":"2020-12-31","value":0.02,"profit":true},{"date":"2021-12-31","value":0.05,"profit":true},{"date":"2022-12-31","value":0.1,"profit":true},{"date":"2023-12-31","value":0.17,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(6.64M)(14.54M)(25.51M)(45.04M)(26.69M)[{"date":"2020-12-31","value":-664022100,"profit":false},{"date":"2021-12-31","value":-1453722100,"profit":false},{"date":"2022-12-31","value":-2551127900,"profit":false},{"date":"2023-12-31","value":-4503501100,"profit":false},{"date":"2024-12-31","value":-2669492800,"profit":false}]
Total Non-Operating Income/Expense1.23M63.42K365.42K(10.49M)2.10M[{"date":"2020-12-31","value":58.23,"profit":true},{"date":"2021-12-31","value":3.01,"profit":true},{"date":"2022-12-31","value":17.36,"profit":true},{"date":"2023-12-31","value":-498.6,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(5.46M)(14.49M)(25.33M)(56.20M)(24.59B)[{"date":"2020-12-31","value":-546204700,"profit":false},{"date":"2021-12-31","value":-1448713200,"profit":false},{"date":"2022-12-31","value":-2532856700,"profit":false},{"date":"2023-12-31","value":-5620431300,"profit":false},{"date":"2024-12-31","value":-2459037500000,"profit":false}]
Income Taxes(1.20M)(50.09K)(182.71K)(45.03K)(24.59B)[{"date":"2020-12-31","value":-120467400,"profit":false},{"date":"2021-12-31","value":-5008900,"profit":false},{"date":"2022-12-31","value":-18271200,"profit":false},{"date":"2023-12-31","value":-4503500,"profit":false},{"date":"2024-12-31","value":-2459037500000,"profit":false}]
Income After Taxes(4.26M)(14.44M)(25.15M)(56.16M)-[{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(5.46M)(14.49M)(25.33M)(41.72M)(24.59M)[{"date":"2020-12-31","value":-546204700,"profit":false},{"date":"2021-12-31","value":-1448713200,"profit":false},{"date":"2022-12-31","value":-2532856700,"profit":false},{"date":"2023-12-31","value":-4171708600,"profit":false},{"date":"2024-12-31","value":-2459037500,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(4.26M)(14.44M)(25.15M)(56.20M)(24.59B)[{"date":"2020-12-31","value":-425737300,"profit":false},{"date":"2021-12-31","value":-1443704300,"profit":false},{"date":"2022-12-31","value":-2514585500,"profit":false},{"date":"2023-12-31","value":-5620431300,"profit":false},{"date":"2024-12-31","value":-2459037500000,"profit":false}]
EPS (Diluted)(0.84)(1.90)(3.77)(6.13)(2.44)[{"date":"2020-12-31","value":-84,"profit":false},{"date":"2021-12-31","value":-190,"profit":false},{"date":"2022-12-31","value":-377,"profit":false},{"date":"2023-12-31","value":-613,"profit":false},{"date":"2024-12-31","value":-244,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ANVS
Cash Ratio 2.72
Current Ratio 3.59

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ANVS
ROA (LTM) -138.27%
ROE (LTM) -3159.09%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ANVS
Debt Ratio Lower is generally better. Negative is bad. 0.33
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.67

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ANVS
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 3.25
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Annovis Bio Inc share price today?

Annovis Bio Inc (ANVS) share price today is $1.55

Can Indians buy Annovis Bio Inc shares?

Yes, Indians can buy shares of Annovis Bio Inc (ANVS) on Vested. To buy Annovis Bio Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ANVS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Annovis Bio Inc be purchased?

Yes, you can purchase fractional shares of Annovis Bio Inc (ANVS) via the Vested app. You can start investing in Annovis Bio Inc (ANVS) with a minimum investment of $1.

How to invest in Annovis Bio Inc shares from India?

You can invest in shares of Annovis Bio Inc (ANVS) via Vested in three simple steps:

  • Click on Sign Up or Invest in ANVS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Annovis Bio Inc shares
What is Annovis Bio Inc 52-week high and low stock price?

The 52-week high price of Annovis Bio Inc (ANVS) is $17.88. The 52-week low price of Annovis Bio Inc (ANVS) is $1.11.

What is Annovis Bio Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Annovis Bio Inc (ANVS) is 3.25

What is the Market Cap of Annovis Bio Inc?

The market capitalization of Annovis Bio Inc (ANVS) is $26.31M

What is Annovis Bio Inc’s stock symbol?

The stock symbol (or ticker) of Annovis Bio Inc is ANVS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top